Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
+$953M |
| 2 |
NVIDIA
NVDA
|
+$784M |
| 3 |
Meta Platforms (Facebook)
META
|
+$753M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$316M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$315M |
Top Sells
| 1 |
Amazon
AMZN
|
+$1.17B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$506M |
| 4 |
Abbott
ABT
|
+$388M |
| 5 |
Johnson & Johnson
JNJ
|
+$325M |
Sector Composition
| 1 | Technology | 20.29% |
| 2 | Healthcare | 16.94% |
| 3 | Consumer Discretionary | 12.83% |
| 4 | Consumer Staples | 9.16% |
| 5 | Industrials | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Mativ Holdings
MATV
$675M
| $755K | ﹤0.01% |
49,922
+5,610
| +13% | +$84.8K |
|
2652
Praxis Precision Medicines
PRAX
$927M
| $754K | ﹤0.01% |
43,720
+18,387
| +73% | +$317K |
|
2653
iShares 20+ Year Treasury Bond BuyWrite Strategy ETF
TLTW
$1.38B
| $754K | ﹤0.01% |
+22,500
| New | +$754K |
|
2654
Dimensional US Core Equity Market ETF
DFAU
$9.28B
| $753K | ﹤0.01% |
24,300
+9,000
| +59% | +$279K |
|
2655
Schwab Fundamental International Small Company Index ETF
FNDC
$3.05B
| $753K | ﹤0.01% |
22,700
-17,951
| -44% | -$595K |
|
2656
Everest Group
EG
$14B
| $752K | ﹤0.01% |
2,200
-4,700
| -68% | -$1.61M |
|
2657
Merchants Bancorp
MBIN
$1.45B
| $752K | ﹤0.01% |
29,400
-10,700
| -27% | -$274K |
|
2658
Orion Group Holdings
ORN
$313M
| $751K | ﹤0.01% |
267,139
+14,942
| +6% | +$42K |
|
2659
Schneider National
SNDR
$4.08B
| $749K | ﹤0.01% |
+26,080
| New | +$749K |
|
2660
iShares Global Energy ETF
IXC
$1.87B
| $744K | ﹤0.01% |
+20,000
| New | +$744K |
|
|
AZRE
2661
DELISTED
Azure Power Global Limited
AZRE
| $744K | ﹤0.01% |
420,316
+193,960
| +86% | +$343K |
|
2662
Amtech Systems
ASYS
$125M
| $742K | ﹤0.01% |
77,661
+2,114
| +3% | +$20.2K |
|
2663
SPDR Bloomberg Barclays International Treasury Bond ETF
BWX
$1.39B
| $742K | ﹤0.01% |
32,900
+2,501
| +8% | +$56.4K |
|
2664
Arbutus Biopharma
ABUS
$849M
| $739K | ﹤0.01% |
321,128
+46,137
| +17% | +$106K |
|
2665
Enliven Therapeutics
ELVN
$1.13B
| $738K | ﹤0.01% |
36,150
-34,108
| -49% | -$696K |
|
|
IMAB
2666
I-MAB
IMAB
$301M
| $736K | ﹤0.01% |
246,308
+38,500
| +19% | +$115K |
|
2667
Provident Bancorp
PVBC
$226M
| $736K | ﹤0.01% |
88,880
-111,192
| -56% | -$921K |
|
2668
Vanguard Small-Cap Growth ETF
VBK
$20.5B
| $735K | ﹤0.01% |
+3,200
| New | +$735K |
|
|
NM
2669
DELISTED
Navios Maritime Holdings Inc.
NM
| $733K | ﹤0.01% |
446,770
-35,512
| -7% | -$58.3K |
|
2670
Avidity Biosciences
RNA
$5.15B
| $731K | ﹤0.01% |
65,900
-309,200
| -82% | -$3.43M |
|
|
SNT
2671
Senstar Technologies
SNT
$99.2M
| $731K | ﹤0.01% |
603,846
-19,523
| -3% | -$23.6K |
|
|
EFTR
2672
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $731K | ﹤0.01% |
35,236
+29,480
| +512% | +$612K |
|
2673
Porch Group
PRCH
$1.89B
| $730K | ﹤0.01% |
529,000
+517,400
| +4,460% | +$714K |
|
2674
Co-Diagnostics
CODX
$16.1M
| $726K | ﹤0.01% |
653,700
+5,400
| +0.8% | +$6K |
|
2675
Imperial Oil
IMO
$48.1B
| $726K | ﹤0.01% |
14,195
-104,014
| -88% | -$5.32M |
|